Olly Morgan and Mac Tuncer, who previously scaled a leading UK provider of personalized 3D-printed orthopaedic implants before exiting in 2024, are now aiming to shift the paradigm for younger knee osteoarthritis patients with their new venture, Vitalis Ortho. The company has secured $1.6M in pre-seed funding.
Vitalis Ortho seeks to make joint preservation the default for the 37% of patients under 65 who currently face limited options between pain management and a knee replacement. Investors in the round include Zinc, Aligned Syndicate, Orthopaedic Research UK, and Innovate UK.















